Altesa BioSciences
PrivateLast Round
Series B
Feb 19, 2026
Est. Valuation
$190M
Total Funding Raised
$153M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Altesa BioSciences is a biotechnology company that develops antiviral drugs to treat respiratory infections and chronic lung diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altesa BioSciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Altesa BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 19, 2026 | ||||
| Series A | Jul 1, 2023 | ||||
| Series A | Dec 22, 2022 | ||||
| Seed | Feb 10, 2022 | ||||
| Seed | Jan 1, 2022 |
Key People
Founding team and executive leadership
Altesa BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| Forbion | Series B |
| Georgia Research Alliance | Series A, Seed |
| Atlantic Partners | Series B |
| Medicxi | Series B, Series A |
| Pitango Venture Capital | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
$75M round completed.
- Sep 16, 2025
Partnered with BioMérieux for Phase IIb trial of vapendavir.
Altesa BioSciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Altesa BioSciences's valuation, stock price, and market status.